Event Details

TSANZ Position Paper Webinar: Treatment of Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis. 

In this webinar we will present a summary of the latest TSANZ position paper on the Sputum Induction. To view the paper click here Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision - Mackintosh - 2024 - Respirology - Wiley Online Library

Date: Friday 30th August 2024 

Time: 12:00pm - 13:30pm AEST

Webinar Topic:

 The session will cover both pharmacological and non-pharmacological aspects of managing IPF and PPF. 

Chairs: Dr. Gregory Keir and Professor Tamera Corte 

Speaker

•  Dr. John Mackintosh - The Prince Charles Hospital

John is a clinician researcher in the field of respiratory and lung transplant medicine, and currently practices as a consultant respiratory physician at The Prince Charles Hospital, Brisbane. John has a particular interest in interstitial lung disease having completed a clinical fellowship in interstitial lung disease in 2018 at The Royal Brompton Hospital, London. John provides a dedicated interstitial lung disease outpatient service and is co-chair of the Queensland Statewide Interstitial Lung Disease Multi-Disciplinary Meeting that provides diagnostic and management advice to physicians across Australia. He has a number of active research studies funded through the NHMRC and MRFF and is principal investigator of multiple phase 1 to 3 clinical trials in ILD.John is a clinician researcher in the field of respiratory and lung transplant medicine, and currently practices as a consultant respiratory physician at The Prince Charles Hospital, Brisbane. John has a particular interest in interstitial lung disease having completed a clinical fellowship in interstitial lung disease in 2018 at The Royal Brompton Hospital, London. John provides a dedicated interstitial lung disease outpatient service and is co-chair of the Queensland Statewide Interstitial Lung Disease Multi-Disciplinary Meeting that provides diagnostic and management advice to physicians across Australia. He has a number of active research studies funded through the NHMRC and MRFF and is principal investigator of multiple phase 1 to 3 clinical trials in ILD.